期刊文献+

长双歧杆菌分泌型表达载体的构建及Tum-5基因的表达 被引量:2

Construction of a Bifidobacterium longum secretory expression vector and expression of gene Tum-5
原文传递
导出
摘要 目的构建能在双歧杆菌内稳定存在并高效分泌表达外源基因的长双歧杆菌质粒表达载体。方法以质粒p BAD/glll为基础,以双歧杆菌内源性阿拉伯糖苷酶的分泌性信号肽取代质粒原有的分泌性信号肽,并将双歧杆菌天然质粒的聚合酶基因克隆入载体中,构建表达载体p BBADs。将人Tum-5基因克隆入载体中,构建质粒p BBADs-Tum-5,电转化长双歧杆菌NCC2705,L-阿拉伯糖诱导表达后,Western Blot鉴定基因表达。结果成功地构建了长双歧杆菌分泌型质粒表达载体,Tum-5基因在双歧杆菌内可以表达。结论构建的表达载体为双歧杆菌用于肿瘤靶向基因治疗奠定了基础。 Objective To construct a stable secretory expression vector of Bifidobacterium longum. Methods Using plasmid pBAD/glll as a basis, replaced the original signal peptide sequence with Bifidobacterium endogenous arabinosidase signal peptide sequence, then the Bifidobacterium plasmid polymerase gene (BPP) was cloned into the vector. The expression vector was named pBBADs. The human Turn-5 gene was cloned into the vector. The plasmid pBBADs-Tum-5 was transformed into B. longum NCC2705 by electroporation. After L-arabinose induc- tion, the expression of Tum-5 in B. longum was detected by Western Blot. Results The secretory expression vector of B. longum was constructed successfully, and Turn-5 gene was expressed in Bifidobacterium. Conclusion The construction of the vector has laid foundation for tumor-targeting gene therapy with B. longum.
出处 《中国微生态学杂志》 CAS CSCD 2014年第12期1365-1369,共5页 Chinese Journal of Microecology
基金 深圳市科技计划项目(201303036) 深圳市科技计划重点项目(201201013) 广东省自然基金资助课题(10151802001000002)
关键词 双歧杆菌 表达载体 Tum-5 Bifidobacterium longum Expressive vector Turn-5
  • 相关文献

参考文献13

  • 1Reid G, Sanders ME, Gaskins HR, et al. New scientific paradigms for probiotics and prebiotics [ J ]. J Clin Gastroenterol, 2003, 37 (2): 105-111.
  • 2Baban CK, Michelle C, O'Hanlon D, et aI. Bacteria as vectors for gene therapy of cancer [ J ]Bioengineered Bugs, 2010, 6 ( 1 ) : 385 -394.
  • 3Lemmon M J, van Zijl P, Fox ME, et al. Anaerobic bacteria as a gene delivery system that controlled by the tumor microenvironment [J].GeneTher, 1997, 4(8): 791-796.
  • 4Hu B, Kou L, Li C, et al. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth [ J ]. Cancer Gene Ther, 2009, 16(8): 655-663.
  • 5Fujimori M, Amano J, Taniguchi S, et al. The genus Bifidobacteri- um for cancer gene therapy [ J ]. Curr Opin Drug Discov Devel, 2002, 5(2): 220-233.
  • 6Maeshima Y, Yerramala UL, Dhanabal M, et al. Extracellular matrix-derived peptide binds to alpha(v) beta(3 )integrin and inhib- its angiogenesis[ J]. J Bid Chem, 2001, 276(34) : 31959-31968.
  • 7Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors [ J ]. Cancer gene Ther, 2000, 7 ( 2 ) : 269 -274.
  • 8Liu Y, Zhou M, Luo D, et al. Bacteria-mediated in vivo delivery of quantum dots into solid tumor[ J]. Bioehem Biophys Res Commun, 2012, 425(4): 769-774.
  • 9Floquet N, Pasco S, Ramont L, et al. The antitumor properties of the alpha3 (IV) (185-203) peptide from the NCI domain of type IV collagen(tumstatin) are conformation-dependent[J]. J Biol Chem, 2004, 279(3): 2091-2100.
  • 10Pasco S, Ramont L, Venteo L, et al. In vivo overexpression of tumstatin domain by tumor cells inhibits their invasive properties in a mouse melanoma model [ J ]. Exp Cell Res, 2004, 301 (2) : 251-265.

二级参考文献14

  • 1ChengYI,YingHUANG,Zhi-yingGUO,Shu-renWANG.Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma[J].Acta Pharmacologica Sinica,2005,26(5):629-634. 被引量:22
  • 2李迎雪,王立生.双歧杆菌作为基因治疗转移载体的研究进展[J].中国微生态学杂志,2006,18(1):76-77. 被引量:3
  • 3朱忠生,王立生,曾位森,郑跃杰,罗深秋,李迎雪,姜泊,潘令嘉,周殿元.一株双歧杆菌质粒聚合酶基因的PCR扩增和鉴定[J].中国微生态学杂志,2007,19(4):321-323. 被引量:5
  • 4陈学聪.厌氧菌及其感染[M].上海:上海医科大学出版社,1989.187-188.
  • 5REID G,SANDERS M E,GASKINS H R,et al.New scientific paradigms for probiotics and prebiotics[J].J Clin Gastroenterol,2003,37(2):105-111.
  • 6PARK M S,SHIN D W,LEE K H,et al.Sequence analysis of plasmid pKJ50 from Bifidobacterium longum[J].Microbiology,1999,145 (3):585-592.
  • 7萨母布鲁克 J,弗里奇 E F,曼尼阿蒂斯 T.分子克隆实验指南[M].第2版.金冬雁,黎孟枫译.北京:科学出版社,1998.
  • 8YAZAWA K,FUJIMORI M,AMANO J,et al.Bifidobacterium longum as a delivery system for cancer gene therapy:Selective localization and growth in hypoxic tumors[J].Cancer Gene Ther,2000,7 (2):269-274.
  • 9LI X,FU G F,FAN Y R,et al.Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy:selective inhibitor of angiogenesis and hypoxic tumor growth[J].Cancer Gene Ther,2003,10(2):105-111.
  • 10SGORBATI B,SCARDOVI V,LEBLANC D J.Plasmids in the genus Bifidobacterium[J].J Gen Microbiol,1982,128(9):2121-2131.

共引文献4

同被引文献28

  • 1王世军,孙静,张栋,郭继龙,简隆磊,刘铠.鸡胚尿囊膜血管生长的特点及观测方法[J].生物医学工程研究,2004,23(1):38-40. 被引量:16
  • 2Kim HS, Jeong HY, Lee YK, et al.Synergistic antitumoral effect of IL-12 gene cotransfected with antiangiogenic genes for angiostatin, end-ostatin, and saxatilin[J].Oncol Res, 2013,21(4):209-216.
  • 3Itokawa Y, Mazda 0,Ueda Y, et al.Interleukin-12 genetic administra-tion suppressed metastatic liver tumor unsusceptible to CTL[J].Bio-chem Biophys Res Commun,2004,314(4): 1072-1079.
  • 4Garcia Paz F, Madrid Marina V, Morales Ortega A, et al.The relation-ship between the anti tumor effect of the IL-12 gene therapy and the ex-pression of Thl cytokines in an HPV16-positive murine tumor model[J].Mediators Inflamm, 2014,510846.
  • 5Pert! U, Luster AD, Varki NM,et al.IFN-^-inducible protein-10 is es-sential for the generation of a protective tumor-specific CD8 T cell re-sponseinduced by single-chain IL-12 gene therapy[J]J Immunol,2001,166(11):6944-6951.
  • 6Zhang YL,Ltl R, Chang ZS, et al. Clostridium sporogenes delivers inter-leukin- 12 to hypoxic tumours, producing antitumour activity withoutsignificant toxicity[J].Lett Appl Microbiol, 2014,59(6):580-586.
  • 7Baban CK.Michelle C,0,Hanlon D,et al. Bacteria as vectors for genetherapy of cancer[J].Bioengineered Bugs, 2010,6( 1) : 385-394.
  • 8Lemmon MJ, van Zijl P, Fox ME, et al. Anaerobic bacteria as a genedelivery system that controlled by the tumor microenvironment[J].Gene Ther, 1997,4(8) :791-796.
  • 9Hu B,Kou L,Li C,et al. Bifidobacterium longum as a delivery systemof TRAIL and endostatin cooperates with chemotherapeutic drugs to in-hibit hypoxic tumor growth[J]. Cancer Gene Ther, 2009,16(8) : 655-663.
  • 10Fujimori M, Amano J, Taniguchi S, et al. The genus Bifidobacteriumfor cancer gene therapy[J]. Cuit Opin Drug Discov Devel, 2002, 5(2):220-233.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部